Inventor · disambiguated record
Noelynn A. Oliver
Also filed as: OLIVER NOELYNN A
5 granted patents·8 pending applications·67 citations·filing 2002–2022
80Inventor score
Top patents by PatentIndex Score
13 records- 0193US7405274B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2004·Granted Jul 29, 2008·47 cites·28 claims
- 0292US7871617B2Antibodies that bind to a portion of the VWC domain of connective tissue growth factorFIBROGEN INC·Filed 2008·Granted Jan 18, 2011·16 cites·45 claims
- 0384US2024076364A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2022·Application pending·0 cites
- 0475US9034643B2Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2012·Granted May 19, 2015·1 cites·12 claims
- 0574US2021230259A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2020·Application pending·0 cites
- 0671US8771692B2Methods for treatment of muscular dystrophyBRANDAN ENRIQUE·Filed 2010·Granted Jul 8, 2014·3 cites·12 claims
- 0767US2019023778A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2018·Application pending·0 cites
- 0860US2016257740A1Connective Tissue Growth Factor AntibodiesFIBROGEN INC·Filed 2016·Application pending·0 cites
- 0957US2011091468A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2010·Application pending·0 cites
- 1057US2016024198A1Connective tissue growth factor antibodiesFIBROGEN INC·Filed 2015·Application pending·0 cites
- 1138US8314059B2Diabetic nephropathy therapiesFLYVBJERG ALLAN·Filed 2010·Granted Nov 20, 2012·0 cites·4 claims
- 1237US2005214294A1Diabetic nephropathy therapiesFLYVBJERG ALLAN·Filed 2005·Application pending·0 cites
- 1333US2003153524A1Methods for inhibiting ocular processesFiled 2002·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →